Predict your next investment

Corporate Venture
mblvc.co.jp

See what CB Insights has to offer

Investments

12

Portfolio Exits

1

Funds

1

About MBL Venture Capital

MBL Venture Capital is the investment arm of Medical & Biological Laboratories Co. The firm primarily invests in seed, start-up, early, middle to later stage venture companies, including university and research institute-based ventures. The Venture prefers to invest mainly in biotechnology, life science, drug discovery and regenerative medicine sectors in conjunction with IT applications, some of which are bio-informatics, medical diagnostics and devices, and medical services among others.

MBL Venture Capital Headquarters Location

5-3 Sakae 4 chome Naka-ku, Nagoya

Aichi, 460-0008,

Japan

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

MBL Venture Capital Investments

12 Investments

MBL Venture Capital has made 12 investments. Their latest investment was in J-Pharma as part of their Series D on July 7, 2020.

CBI Logo

MBL Venture Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/30/2020

Series D

J-Pharma

$16.32M

Yes

3

3/30/2018

Series A

Himuka AM Pharma

$3.31M

Yes

1

9/29/2017

Series A

Thermalin

$17.12M

Yes

3

4/4/2017

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/26/2016

Series B

Subscribe to see more

Subscribe to see more

10

Date

7/30/2020

3/30/2018

9/29/2017

4/4/2017

12/26/2016

Round

Series D

Series A

Series A

Series A

Series B

Company

J-Pharma

Himuka AM Pharma

Thermalin

Subscribe to see more

Subscribe to see more

Amount

$16.32M

$3.31M

$17.12M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

3

10

10

MBL Venture Capital Portfolio Exits

1 Portfolio Exit

MBL Venture Capital has 1 portfolio exit. Their latest portfolio exit was LivTech on December 25, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/25/2014

Acquired

$99M

Undisclosed Investors

Date

12/25/2014

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Undisclosed Investors

Sources

MBL Venture Capital Fund History

1 Fund History

MBL Venture Capital has 1 fund, including JSR mblVC Life Science Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

JSR mblVC Life Science Fund

Multi-Stage Venture Capital

Closed

1

Closing Date

Fund

JSR mblVC Life Science Fund

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

Sources

1

MBL Venture Capital Team

1 Team Member

MBL Venture Capital has 1 team member, including current Chief Executive Officer, Yasuyo Kayama.

Name

Work History

Title

Status

Yasuyo Kayama

Chief Executive Officer

Current

Name

Yasuyo Kayama

Work History

Title

Chief Executive Officer

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.